Copyright © APPLIED MOLECULAR TRANSPORT, LLC 2016. All rights reserved.

We are developing an internal pipeline of biological therapeutics, while actively pursuing partnerships with investors and biopharmaceuticals developers, in the following areas:


  • GI-targeted biopharmaceuticals that access novel inflammation and autoimmune targets along the gut (such as Regulatory T cells)
  • RNA interference (local GI and systemic)
  • ‘Bio-betters’: Converting parenteral biologics and peptides to oral dosage forms, particularly for treating metabolic diseases with improved pharmacology

STRATEGY